Mariano Rodriguez

Identification of the Vasoconstriction-Inhibiting Factor (VIF), a Potent Endogenous Cofactor of Angiotensin II Acting on the Angiotensin II Type 2 Receptor

G. Heinze, J. Jankowski, N. Marx, 2015, Circulation.

Normal and pathologic concentrations of uremic toxins.

Raymond Vanholder, Joachim Jankowski, J. Jankowski, 2012, Journal of the American Society of Nephrology : JASN.

Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro--towards a standardized approach for research on uraemia.

J. Jankowski, Z. Massy, R. Vanholder, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro--towards a standardized approach for research on uraemia.

J. Jankowski, Z. Massy, R. Vanholder, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Identification of the “ Vasoconstriction Inhibiting Factor” ( VIF ), a Potent Endogenous Cofactor of Angiotensin II Acting on the AT2 Receptor

J. Jankowski, N. Marx, J. Muñoz-Castañeda, 2015 .

Review on uremic toxins: classification, concentration, and interindividual variability.

Raymond Vanholder, Peter Stenvinkel, Ciro Tetta, 2003, Kidney international.

Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in vitro Evaluation

J. Jankowski, Z. Massy, R. Vanholder, 2010, Blood Purification.

Is Plasma Proteomics Able to Provide Alternative Paths to Better Understand Hypertension?

À. Argilés, Mariano Rodriguez, A. Ortíz, 2017, Hypertension.